Secondhand Smoke: What the Evidence Says About Risk to Others

The 2006 Surgeon General’s report on secondhand smoke reached a conclusion that remains unchanged: there is no risk-free level of exposure to secondhand smoke [1]. The evidence supporting this is large: secondhand smoke exposure causes approximately 41,000 deaths per year among non-smoking adults in the US, primarily from cardiovascular disease and lung cancer. Globally, the estimate is roughly 603,000 deaths per year [5]. For many smokers, the risk to others is a stronger motivation to quit than the risk to themselves, and the evidence justifies that instinct.

What secondhand smoke contains

Secondhand smoke is a mixture of two components: sidestream smoke released from the burning end of the cigarette and mainstream smoke exhaled by the smoker. Sidestream smoke, which makes up the majority of secondhand smoke in a room, is produced at lower combustion temperatures than mainstream smoke. This is not a trivial distinction: lower combustion temperatures generate higher concentrations of certain toxins, including carbon monoxide, benzene, and several nitrosamines. The sidestream component dilutes in room air before reaching a bystander, which reduces the total dose, but it does not reduce the number of distinct toxic compounds present in the exposure.

The result is that a non-smoker in a room with a smoker is exposed to the same categories of harmful chemicals as the smoker: carbon monoxide, particulate matter, volatile organic compounds, heavy metals, and dozens of established carcinogens [1]. The dose is lower than what the active smoker receives, typically by a factor of 100 or more for most compounds. The critical finding in the evidence is that for some health effects, particularly cardiovascular effects, the dose-response relationship is not linear: the first increments of exposure produce disproportionately large effects compared to what a simple dose scaling would predict.

Cardiovascular risk

The cardiovascular effects of secondhand smoke are the largest component of its health impact and account for the majority of secondhand smoke deaths in adults. Non-smokers exposed to secondhand smoke at home or work have a 25-30% increase in coronary heart disease risk [3]. This is a larger increase than might be expected from the relatively lower dose compared to active smoking, and the explanation is physiological: even brief secondhand smoke exposure causes measurable changes in platelet function, endothelial function and arterial stiffness that promote cardiovascular events.

The mechanism is well-characterized. Secondhand smoke exposure increases platelet aggregation, making blood more prone to clotting. It impairs the endothelium’s ability to dilate blood vessels in response to increased flow, which is one of the earliest markers of atherosclerotic disease. It increases oxidative stress, which damages the vessel lining and promotes the inflammatory cascade that underlies plaque formation. These effects occur rapidly: measurable changes in platelet function have been documented within minutes of exposure, and endothelial dysfunction has been observed after as little as 30 minutes in a smoke-filled environment [3].

The steep dose-response curve at low exposure levels explains why the cardiovascular risk from secondhand smoke is disproportionate to the dose. An active smoker’s cardiovascular risk increases roughly linearly with the number of cigarettes smoked, but a non-smoker’s cardiovascular risk increases sharply with even modest exposure before the curve flattens at higher exposure levels. The practical consequence is that the difference between no exposure and some exposure is larger, in relative terms, than the difference between moderate exposure and heavy exposure.

The natural experiment of public smoking bans confirms this relationship in population data. A meta-analysis of studies following the implementation of smoking bans in workplaces and public places found a 17% decrease in hospital admissions for heart attacks in the affected populations [4]. This decrease appeared within months of the bans taking effect, consistent with the rapid cardiovascular response to reduced exposure. The speed of the effect, measurable within the first year of the bans, corresponds to the speed at which the acute cardiovascular effects of secondhand smoke exposure resolve when the exposure stops.

Lung cancer risk

Secondhand smoke is classified as a Group 1 carcinogen by the International Agency for Research on Cancer, meaning it is known to cause cancer in humans. A meta-analysis of studies on spousal smoking found a 20-30% increase in lung cancer risk among non-smoking spouses of smokers [2]. The risk is dose-dependent: longer duration and higher intensity of exposure increase risk, but the relationship is present even at lower levels of exposure.

The carcinogenic mechanism follows the same pathways as active smoking, through exposure to the same carcinogens at lower doses. The lung tissue of non-smokers exposed to secondhand smoke shows some of the same DNA adducts (chemical modifications to DNA caused by carcinogen binding) found in active smokers, though at lower levels. The question is not whether secondhand smoke delivers carcinogens to the lungs of bystanders; it does. The question is whether the lower dose translates into lower cancer rates, and the meta-analytic evidence says yes, the rates are lower than in active smokers, but meaningfully higher than in non-exposed non-smokers [2].

Workplace exposure has been particularly well-studied because it represents a sustained, quantifiable exposure pattern. Non-smokers who work in environments where smoking is permitted have measurably higher lung cancer risk than non-smokers in smoke-free workplaces, with the magnitude of the increase related to the duration and intensity of the occupational exposure.

Effects on children

Children are more vulnerable to secondhand smoke than adults for several reasons. Their airways are smaller, they breathe faster relative to body weight (inhaling proportionally more air and more pollutants per kilogram), and their immune and respiratory systems are still developing. The developing lung is more susceptible to the irritant and inflammatory effects of smoke components, and the developing immune system is less able to manage the resulting insult.

Health effect in children	Evidence
SIDS (sudden infant death syndrome)	2-3x increased risk with parental smoking
Asthma	Increased incidence and severity
Ear infections (otitis media)	Increased frequency
Lower respiratory infections	Increased bronchitis, pneumonia
Reduced lung function	Measurable decreases in lung growth

Parental smoking is the primary source of child secondhand smoke exposure. The Surgeon General’s report found that children living with smokers had cotinine levels (a nicotine metabolite used as a biomarker for smoke exposure) substantially higher than children in non-smoking households [1]. Even when parents smoke only outside the home, children’s cotinine levels remain elevated compared to children of non-smoking parents, though the levels are lower than when smoking occurs indoors.

The SIDS risk is among the most consequential findings. The 2-3x increased risk applies to infants exposed to secondhand smoke in the postnatal environment, and the risk increases with the number of smokers in the household and the number of cigarettes smoked. The mechanism is not fully established but is thought to involve effects on the developing brainstem respiratory control centers, combined with the direct respiratory irritant effects of smoke exposure during sleep.

The asthma data is similarly clear: children in smoking households have both higher incidence of new asthma diagnoses and more frequent and severe exacerbations of existing asthma. For a child with established asthma, parental smoking is a modifiable risk factor that a clinician would address as a priority.

Thirdhand smoke

Smoking outdoors or in a separate room reduces but does not eliminate exposure. Thirdhand smoke, the chemical residue that settles on clothing, skin, hair, furniture and other surfaces, represents a persistent exposure source that conventional ventilation does not address [1]. Nicotine and other tobacco smoke components adhere to surfaces, react with other indoor pollutants over time to form new compounds (some of which are carcinogenic), and can be re-emitted into indoor air or absorbed through skin contact.

For young children, thirdhand smoke exposure is a particular concern because of their hand-to-mouth behavior and their proximity to contaminated surfaces (carpets, upholstery, bedding). A smoker who smokes outdoors and then holds an infant is delivering nicotine and other residual compounds through skin and clothing contact. The health effects of thirdhand smoke at these exposure levels are an active area of research and are not yet as well-characterized as the effects of airborne secondhand smoke, but the chemical exposures are real and measurable.

What “no safe level” means in practice

The Surgeon General’s conclusion that there is no risk-free level of exposure is based on the evidence that the cardiovascular effects of secondhand smoke are disproportionately large at low doses [1]. The dose-response curve for cardiovascular effects is steep at the low end: even small exposures cause measurable changes in platelet aggregation and endothelial function. This contrasts with some toxins where effects appear only above a threshold.

In practical terms: ventilation systems, smoking in a different room, and smoking near an open window reduce exposure but do not eliminate risk. Standard household ventilation systems are not designed to remove the fine particulate matter and gas-phase toxins in cigarette smoke. HEPA filters capture particulate matter but not gas-phase compounds. The most effective protection is elimination of the smoke source.

What this means if you’re deciding

For smokers who live with non-smokers, particularly children, the secondhand smoke evidence adds a dimension to the quit decision that is not about the smoker’s own health. The cardiovascular and respiratory risks to household members are real, measurable and begin declining when smoking stops. The cardiovascular benefit to household members appears quickly, consistent with the rapid onset and offset of the acute cardiovascular effects of secondhand smoke exposure.

If quitting is not immediate, moving all smoking outdoors (not in a car, not near windows or doors) reduces household exposure substantially. This is harm reduction, not risk elimination, but it is a meaningful step. Smoking in a car, even with windows open, produces extremely high concentrations of secondhand smoke in the enclosed space and should be avoided entirely when children are present.

For smokers with COPD who live with others, the situation is particularly clear: the smoker’s own disease is being accelerated while simultaneously exposing household members to cardiovascular and respiratory risk. Quitting addresses both. Combination NRT or varenicline, which have the strongest quit rate evidence, are worth discussing with a clinician in this context because the stakes for both the smoker and their household are high.

Open questions

The long-term health effects of sustained low-level secondhand smoke exposure, such as that experienced by workers in partially ventilated hospitality venues, are less precisely quantified than the effects of domestic exposure. The health effects of thirdhand smoke are an active area of research: early evidence suggests that some tobacco smoke chemicals persist on surfaces for extended periods and can be re-emitted or absorbed through skin contact, but the magnitude of health risk from thirdhand smoke exposure is not yet well characterized. Whether e-cigarette aerosol poses secondhand risks comparable to tobacco smoke is a separate question with its own evidence base; the current data suggests the exposure is lower in magnitude but not zero.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.